Exelixis, inc. (EXEL)
Balance Sheet / Quarterly
Apr'20Jan'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

357,340

266,501

242,317

369,789

373,937

314,775

353,623

248,407

232,331

183,164

149,357

135,212

183,179

151,686

111,219

129,827

276,882

141,634

145,642

61,949

84,987

80,395

100,065

147,340

157,539

103,978

92,016

131,774

171,232

170,069

308,805

68,140

70,466

74,257

66,211

75,280

97,440

Short-term investments

597,028

585,742

518,350

452,328

425,713

378,559

281,000

251,516

194,589

204,607

217,741

214,044

241,094

268,117

208,462

198,292

45,235

25,426

52,169

14,648

22,258

63,890

91,937

86,177

116,033

138,475

187,203

220,198

185,332

241,371

163,542

138,901

172,979

120,005

156,947

187,502

65,224

Short-term restricted cash and investments

-

-

-

-

-

-

504

504

504

504

-

-

-

0

-

-

-

-

0

6,109

6,108

12,212

12,210

12,214

12,208

12,213

12,211

12,214

12,206

12,246

12,242

-

-

0

-

-

-

Trade receivables, net

137,338

119,073

169,788

97,541

107,670

162,771

104,634

167,161

91,999

77,300

90,005

43,125

34,076

40,444

91,207

17,799

10,088

5,183

3,470

3,758

3,882

4,882

4,722

5,034

4,457

3,941

5,171

4,209

3,865

2,751

2,708

2,284

1,930

30,190

4,654

6,363

5,896

Other receivables

-

-

13,801

12,390

7,445

-

-

-

-

3,892

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

15,417

12,886

13,366

12,352

10,143

9,838

10,433

8,371

7,563

6,657

5,806

5,425

3,304

3,338

3,292

2,808

2,472

2,616

2,121

2,608

2,593

2,381

3,876

3,026

2,686

2,890

1,764

681

280

0

-

-

-

-

-

-

-

Contract with Customer, Asset, Net, Current

-

-

-

-

7,244

-

24,489

-

31,844

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

29,773

26,988

14,490

12,847

14,146

31,073

12,279

10,327

6,850

8,750

8,012

4,433

6,297

5,416

7,148

4,657

4,791

3,806

3,949

2,731

5,212

3,481

7,860

4,792

5,386

5,112

7,799

5,880

11,030

6,104

6,098

4,498

4,641

4,372

17,062

14,555

14,926

Total current assets

1,136,896

1,011,190

972,112

957,247

946,298

897,016

786,962

686,286

565,680

484,874

470,921

402,239

467,950

469,001

421,328

353,383

339,468

178,665

207,351

91,803

125,040

167,241

220,670

258,583

298,309

266,609

306,164

374,956

383,945

432,541

493,395

213,823

250,016

228,824

244,874

283,700

183,486

Long-term investments

486,036

536,385

486,763

337,785

218,619

158,287

114,093

94,396

96,710

64,255

50,569

26,413

47,351

55,601

55,817

51,727

82,850

83,600

81,600

81,598

81,597

81,579

84,589

95,513

111,155

144,299

157,402

138,125

176,088

182,311

162,173

83,678

84,470

85,260

85,787

86,574

87,314

Long-term restricted cash and investments

-

-

1,000

1,100

1,100

-

1,100

1,100

1,500

4,646

4,650

4,650

4,150

4,150

4,150

4,150

2,650

2,650

2,650

2,684

2,684

4,684

4,684

10,781

10,814

16,897

15,889

21,956

21,899

27,964

27,946

4,067

4,199

4,199

4,199

4,199

6,399

Property and equipment, net

48,489

48,892

49,467

50,709

50,553

50,897

51,046

64,744

45,412

25,743

19,256

18,684

2,594

2,071

1,737

1,982

1,813

1,434

1,448

1,812

2,158

2,432

2,928

4,052

4,685

4,910

5,520

5,650

5,786

6,059

6,292

6,439

7,326

8,506

10,196

11,903

15,811

Operating lease right-of-use assets

-

-

17,735

16,573

13,921

-

5,989

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets, net

163,187

172,374

186,836

210,237

243,717

244,111

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

63,684

Other long-term assets

57,312

53,145

7,268

5,763

3,902

8,291

1,492

948

1,929

12,092

692

862

1,251

1,232

1,774

2,210

2,068

2,309

6,508

7,197

7,771

3,649

7,101

8,022

8,918

6,888

7,300

7,713

8,125

8,538

9,123

2,797

2,905

2,789

2,896

4,122

4,096

Total assets

1,955,604

1,885,670

1,784,865

1,643,098

1,541,794

1,422,286

1,024,366

911,158

774,915

655,294

609,772

516,532

586,980

595,739

548,490

477,136

492,533

332,342

363,241

248,778

282,934

323,269

383,656

440,635

497,565

503,287

555,959

612,084

659,527

721,097

762,613

374,488

412,600

393,262

411,636

454,182

360,790

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

15,321

11,581

8,352

12,274

9,748

10,901

8,679

13,023

11,078

9,575

5,988

7,037

4,649

6,565

3,965

5,435

5,657

6,401

2,256

3,398

1,303

6,413

3,362

4,638

4,943

9,345

3,559

3,458

3,498

4,398

3,246

2,931

1,878

1,957

3,390

2,298

2,046

Accrued compensation and benefits

26,687

37,364

31,713

24,144

22,550

32,142

27,283

21,538

20,756

21,073

19,914

15,555

14,490

20,334

15,986

10,307

6,042

3,629

3,725

3,249

3,459

3,350

6,441

9,856

8,088

12,797

9,342

8,127

6,500

10,375

8,255

7,914

6,586

8,423

8,835

8,159

6,555

Accrued clinical trial liabilities

34,969

38,777

30,330

23,709

23,055

18,231

18,958

16,801

15,351

19,849

16,181

14,680

14,478

14,131

14,887

15,681

16,135

18,071

29,788

32,572

30,976

41,545

45,102

41,367

39,118

34,958

35,042

29,406

21,263

20,560

23,701

23,982

21,634

21,729

24,957

28,761

30,975

Rebates and fees due to customers

23,006

18,719

16,782

17,273

19,708

14,954

11,689

11,143

11,989

7,565

-

-

-

3,420

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued collaboration liabilities

8,663

11,856

7,973

7,847

7,556

7,419

8,397

7,713

7,974

8,974

9,137

7,919

-

2,046

18,710

16,993

14,674

10,938

-

-

-

732

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

-

-

-

321

2,376

-

0

5,939

0

31,984

31,377

31,255

30,662

19,665

18,939

14,631

14,371

0

0

0

7

2,583

1,319

1,127

1,243

1,450

1,017

1,507

9,211

16,321

24,134

31,253

31,253

41,920

76,639

99,603

100,297

Convertible notes

-

-

-

-

-

-

-

-

-

-

0

0

113,349

109,122

29,365

27,500

27,500

0

450

0

3,911

97,449

96,496

94,207

0

10,000

10,000

10,000

10,000

10,000

10,000

10,000

10,000

0

28,900

28,900

28,900

Term loan payable

-

-

-

-

-

-

-

-

-

-

0

0

0

80,000

80,000

80,000

-

0

0

0

164

381

757

1,077

1,392

1,762

2,127

2,546

2,858

3,170

3,164

3,158

4,015

4,870

5,974

7,628

8,848

Other current liabilities

31,831

24,449

45,919

25,228

40,139

21,825

15,900

23,787

17,711

16,150

26,356

21,225

24,659

13,503

19,791

22,248

13,671

13,212

15,969

15,803

13,867

11,550

13,855

15,859

11,974

13,116

13,017

15,362

10,392

11,795

8,882

6,425

8,218

8,943

15,195

15,569

15,026

Current portion of restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,017

-

3,734

5,294

4,993

6,426

6,580

3,726

4,298

4,425

3,776

4,194

4,077

5,085

4,033

4,484

3,875

4,483

2,725

2,624

7,294

Total current liabilities

140,477

142,746

141,069

110,796

125,132

105,472

90,906

99,944

84,859

115,170

108,953

97,671

202,287

268,786

201,643

192,795

101,067

52,251

55,922

60,316

58,680

170,429

173,912

171,857

71,056

87,853

77,880

74,600

67,799

81,704

85,415

90,147

87,459

92,325

166,615

193,542

199,941

Long-term portion of lease liabilities

-

-

23,705

22,543

19,958

-

12,619

-

-

14,938

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract with Customer, Liability, Noncurrent

14,133

6,600

15,400

16,632

8,323

15,900

2,268

11,970

3,177

238,520

246,092

253,663

261,236

237,094

232,573

180,838

184,431

0

-

-

-

-

-

-

-

-

-

-

-

-

0

695

8,508

16,321

50,968

152,670

202,472

Long-term portion of operating lease liabilities

47,883

48,011

-

-

-

12,099

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of operating lease liabilities

-

-

-

-

-

12,178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing obligation for build-to-suit lease

-

-

-

-

-

-

-

20,646

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81,493

288,555

281,156

337,937

297,436

291,225

284,355

179,135

177,962

173,635

261,408

255,147

248,707

242,459

236,385

240,476

239,244

85,862

83,578

91,385

89,295

87,288

83,396

Long-term portion of term loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

80,000

80,000

80,000

80,000

80,000

80,000

80,000

80,055

80,219

80,328

80,757

81,132

81,611

82,090

82,885

83,678

84,470

85,260

85,787

86,574

87,314

Long-term portion of restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

516

-

2,230

3,080

3,697

4,365

5,521

6,743

7,933

9,047

10,126

11,679

12,767

14,137

6,456

7,499

8,481

9,495

7,670

7,478

6,987

Other long-term liabilities

5,459

2,347

975

4,495

3,361

1,286

2,607

3,630

17,113

1,705

16,012

16,687

3,707

541

759

1,082

1,317

2,960

1,881

2,345

2,961

4,169

4,772

5,102

5,467

4,674

5,726

5,882

6,113

6,256

7,768

7,558

7,755

7,844

8,247

8,445

9,005

Total liabilities

207,952

199,700

181,148

154,466

156,774

134,833

108,400

136,190

105,149

370,333

371,057

368,021

467,230

506,421

516,468

663,270

648,487

473,148

437,469

436,966

429,693

438,098

442,167

437,392

426,083

437,049

423,196

415,752

404,675

424,663

421,768

275,439

280,251

302,630

408,582

535,997

589,115

Commitments

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000 shares authorized and no shares issued

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

0

Common stock, $0.001 par value; 400,000 shares authorized; issued and outstanding: 305,780 and 304,831 at March 31, 2020 and December 31, 2019, respectively

306

305

304

303

302

300

299

298

297

296

296

294

292

290

286

230

228

228

225

196

196

196

195

195

194

184

184

184

184

183

183

149

148

135

129

128

109

Additional paid-in capital

2,258,307

2,241,947

2,228,839

2,211,668

2,188,578

2,168,217

2,156,632

2,142,717

2,125,166

2,114,184

2,106,132

2,097,379

2,086,483

2,072,591

2,050,086

1,848,910

1,842,248

1,772,123

1,818,988

1,657,626

1,655,580

1,652,400

1,650,621

1,649,662

1,644,516

1,564,670

1,560,415

1,557,303

1,553,297

1,550,345

1,542,489

1,267,890

1,264,659

1,196,992

1,155,827

1,148,588

953,608

Accumulated other comprehensive income (loss)

-222

3,069

2,668

2,207

728

-701

-513

-731

-887

-347

-52

-119

-326

-416

-80

129

-42

-232

-41

-174

-61

-121

24

177

153

146

180

-263

102

-92

-18

5

50

-138

-249

-13

12

Accumulated deficit

-510,739

-559,351

-628,094

-725,546

-804,588

-880,363

-1,240,452

-1,367,316

-1,454,810

-1,829,172

-1,867,661

-1,949,043

-1,966,699

-1,983,147

-2,018,270

-2,035,403

-1,998,388

-1,912,925

-1,893,400

-1,845,836

-1,802,474

-1,767,304

-1,709,351

-1,646,791

-1,573,381

-1,498,762

-1,428,016

-1,360,892

-1,298,731

-1,254,002

-1,201,809

-1,168,995

-1,132,508

-1,106,357

-1,152,653

-1,230,518

-1,182,054

Total stockholders’ equity

1,747,652

1,685,970

1,603,717

1,488,632

1,385,020

1,287,453

915,966

774,968

669,766

284,961

238,715

148,511

119,750

89,318

32,022

-186,134

-155,954

-140,806

-74,228

-188,188

-146,759

-114,829

-58,511

3,243

71,482

66,238

132,763

196,332

254,852

296,434

340,845

99,049

132,349

90,632

3,054

-81,815

-228,325

Total liabilities and stockholders’ equity

1,955,604

1,885,670

1,784,865

1,643,098

1,541,794

1,422,286

1,024,366

911,158

774,915

655,294

609,772

516,532

586,980

595,739

548,490

477,136

492,533

332,342

363,241

248,778

282,934

323,269

383,656

440,635

497,565

503,287

555,959

612,084

659,527

721,097

762,613

374,488

412,600

393,262

411,636

454,182

360,790